The complete ICD-O code for a neoplasm contains 10 characters. What are the principal parts of the
code and what do they represent? - CORRECT ANSWER✅✅*Grade or differentiation: 1 digit
*Histology (cell type); 4 digits
*Topography (primary site): 4 characters
*Behavior; 1 digit
What is the most important concern in coding neoplasms?
-Control
-Accuracy
-Efficiency
-Speed - CORRECT ANSWER✅✅Accuracy
The Solid Tumor Rules(formerly the MP/H Rules) are the responsibility of this standard-setter:
-NPCR
-ACoS
-SEER
-NAACCR - CORRECT ANSWER✅✅SEER
Staging is defined as - CORRECT ANSWER✅✅a common language developed to communicate
information on the extent of disease
Why do staging systems change over time? - CORRECT ANSWER✅✅New information is found and
changes occur in the practice of medicine.
Which of the following is not a source of information for staging?
-physical therapy report
-radiologic procedure
-endoscopy
, -physical exam
-pathologic examinations - CORRECT ANSWER✅✅physical therapy report
The Hematopoietic and Lymphoid Neoplasm Coding Manual is not used for coding leukemias or
lymphomas.
-true
-false - CORRECT ANSWER✅✅false
The purpose of staging is: (check all that apply)
A-to indicate prognosis.
B-to assess the cancer and choose the appropriate treatment.
C-to estimate survival rate
D-to make a registrars job more challenging - CORRECT ANSWER✅✅A, B, and C
Cancer PathCHART is a resource for both the College of American Pathologists and National Cancer
Institute so that they can share working guidelines and collaborate.
-true
-false - CORRECT ANSWER✅✅True
Grade is a measure of the aggressiveness of the tumor.
-true
-false - CORRECT ANSWER✅✅true
Why must cancer registrars be familiar with the codes in ICD-10 coding? - CORRECT ANSWER✅✅Cancer
registrars must be familiar with codes in the ICD-10 because they are used to code diagnosis and
procedures for all cases along with other data items
Describe at least two differences between ICD-O and ICD-O-3 - CORRECT ANSWER✅✅ICD-O-3
incorporates the WHO classifications for hematopoietic and lymphiod neoplasms. New cytogenic
techniques contributed to the knowledge of lymphomas and leukemias and other bone marrow
conditions, so new codes were added to ICD-O-3 to address that.